Provider review
Jently review
Five different compounds carry exactly the same monthly price.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
We may earn a commission at no extra cost to you. Affiliate partners are listed first on our rankings. How we’re funded.
$124/mo semaglutide, $174/mo tirzepatide, five peptides at $119
Visit JentlyCompounds that differ this much do not converge on one figure by accident — what is priced is the plan, not the drug.
Price as published
Jently
$124/mo semaglutide, $174/mo tirzepatide, five peptides at $119
- Vs median
- $51/mo below the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
The interesting thing here is the shape of the price list rather than any single number in it. Five different compounds — two forms of NAD+, two of sermorelin, and glutathione — all carry exactly the same monthly figure. Things that differ this much in what they are and what they cost to produce do not land on one price by accident, so what is being priced is the plan and the service wrapped around it rather than the medication itself. That is genuinely useful to know before choosing between them: among those five, switching costs nothing at all, and the decision becomes a clinical one rather than a financial one. The two GLP-1 lines are priced separately and differ from each other, which is the ordinary pattern everywhere else. Everything published is a floor, introduced by as low as, with no upper rung anywhere on the site, and no milligram appears against any figure — so none of the seven prices can be attached to a quantity of anything.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You are choosing between several peptides and want the cost to be identical across them
- You want a broad catalog priced on one visible basis
- You want both GLP-1 molecules available from the same provider
Look elsewhere if
- You want to know what a working dose costs. Every figure is a floor
- You expect the price to reflect the compound rather than the plan
- You want a dose behind the number
What it actually costs
Price as published
$124/mo semaglutide, $174/mo tirzepatide, five peptides at $119
- Vs median
- $51/mo below the $175 median across the 299 of 548 programs here that publish a plain monthly rate
- Market
- $59–$1,300/mo is the full published spread on this site
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
235 of the 548 programs here price a small dose this way. Five unrelated compounds at one price tells you what is being sold: the plan and the service, not the drug. Among those five, switching costs nothing and the choice is clinical rather than financial, which is genuinely useful to know. The GLP-1 lines are priced apart and differ, and every one of the seven figures is a floor with nothing published above it. No low-dose product and no dose published.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not confirmed
- Labs
- Not required
- Pricing
- Check plan terms
What it does well
- A broad catalog with every product priced on the same visible basis.
- Switching between the five same-priced compounds costs nothing.
- The two GLP-1 molecules are priced separately and clearly.
Pharmacy, labs and oversight
Jently does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
2 of 4 published openly
What Jently publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere on its own pages.
- Not published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
The interesting thing here is the shape of the price list rather than any single number in it. Five different compounds — two forms of NAD+, two of sermorelin, and glutathione — all carry exactly the same monthly figure. Compounds that differ this much in what they are and what they cost to make do not converge on one price by accident, so what is being priced is the plan and the service wrapped around it rather than the medication itself. That is useful to know before choosing: among those five, switching costs nothing and the decision is a clinical one rather than a financial one. The two GLP-1 lines are priced separately and differ from each other, which is the ordinary pattern. Everything published is a floor, introduced by as low as, with no upper rung anywhere, and no milligram appears against any figure, so none of the seven prices can be attached to a quantity.
The honest cons
Every figure is a floor, and no rung above any of them is published.
- Five unrelated compounds at one price means the drug is not what is being priced.
- No milligram appears against any figure.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Jently is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.
Also consider
Two more programs that price a small dose the way Jently does. Both are partners: we may earn a commission if you start care through these links.
Partner
Sprout Health
$149 sema · $199 tirz
Standard plan, self-directed low dose
FDA warning letter · Sprout Health · September 2025 · addressed to Sprout Health Partners LLC dba Sprout Health. Details in our review.
Partner
Bodybuilding Health+
$179/mo sema · $209/mo tirz
Standard plan, self-directed low dose
Where this sits
#316 of 548
Ordered with the companies that pay us first, and Jently is not one of them. A disclosed partition, not a score.
Compare all 548 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What microdosing GLP-1 costs
- Low dose vs full dose
- The true annual cost of a plan
- What a flat price costs at a low dose
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
HealthRX
$190/mo sema · $239/mo tirz (monthly plan)
- Vs median
- $15/mo above the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the HealthRX review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.